NASDAQ Rheumatology Market News
Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions
First Patient Enrolled in the COAST-1 StudyNon-Opioid, Oral, Targeted, Potentially First-in-Class Mechanism for PainNovel ...
CymaBay Therapeutics Announces Acceptance of Arhalofenate Phase 2b Gout Study Manuscript in Arthritis and Rheumatology
NEWARK, Calif., March 28, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today announced ...
Apricus Reports Top-Line Phase 2b Data for Fispemifene in Symptomatic Secondary Hypogonadism
Fispemifene Failed to Achieve Statistical Significance in Key Clinical Benefit Endpoints Despite Increase in ...
Risk of Work Time Loss Almost Double for Osteoarthritis Sufferers
TORONTO, March 24, 2016 (GLOBE NEWSWIRE) -- Osteoarthritis (OA) sufferers have almost twice the ...
Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2015 Financial Results
Fispemifene Phase 2b Top-Line Data Expected By End of Q1 2016Vitaros Quarterly Unit Sales ...
Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2015 Financial Results
Fispemifene Phase 2b Top-Line Data Expected By End of Q1 2016Vitaros Quarterly Unit Sales ...
UPDATE – TSI Healthcare Named Among Top EHRs for Rheumatology in Black Book Survey
CHAPEL HILL, N.C., March 08, 2016 (GLOBE NEWSWIRE) -- TSI Healthcare, a national leader ...
TSI Healthcare Named Top EHR for Rheumatology in Black Book Survey
CHAPEL HILL, N.C., March 08, 2016 (GLOBE NEWSWIRE) -- TSI Healthcare, a national leader ...
Apricus Biosciences to Present at the 28th Annual ROTH Conference
SAN DIEGO, March 08, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Programs Update
NEW YORK, March 04, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), ...
Apricus Biosciences Closes $10 Million Registered Direct Offering
SAN DIEGO, March 04, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences Announces Corporate Update, Fourth Quarter and Full Year 2015 Financial Results Conference Call
SAN DIEGO, March 02, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...
Apricus Biosciences to Present at the Cowen and Company 36th Annual Health Care Conference
SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical ...